Rare Spontaneous Attenuation of Childhood Inflammatory Cerebral Adrenoleukodystrophy
- PMID: 32774083
- PMCID: PMC7410095
- DOI: 10.1055/s-0039-1677805
Rare Spontaneous Attenuation of Childhood Inflammatory Cerebral Adrenoleukodystrophy
Abstract
X-linked adrenoleukodystrophy (ALD) is a neurodegenerative peroxisomal disorder with variable clinical phenotypes. Childhood cerebral ALD (CCALD) is at the most severe end of the disease spectrum. In CCALD, the clinical manifestations include increasing deficits in behavior, vision, hearing, coordination, and motor function, as well as seizures. Without treatment, CCALD often results in apparent vegetative state within 1 to 2 years of appearance of initial signs and symptoms. We present the case of a boy with classic inflammatory CCALD who exhibited spontaneous attenuation in disease progression. While extremely rare, spontaneous arrest of disease progression may occur in boys with inflammatory CCALD.
Keywords: cerebral adrenoleukodystrophy; inflammatory; spontaneous arrest.
Figures


Similar articles
-
Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.Orphanet J Rare Dis. 2018 Oct 11;13(1):179. doi: 10.1186/s13023-018-0921-4. Orphanet J Rare Dis. 2018. PMID: 30309370 Free PMC article.
-
Childhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden of disease - A population-based study.Orphanet J Rare Dis. 2023 Aug 10;18(1):238. doi: 10.1186/s13023-023-02843-x. Orphanet J Rare Dis. 2023. PMID: 37563635 Free PMC article.
-
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.Ann Neurol. 2011 Sep;70(3):402-9. doi: 10.1002/ana.22486. Epub 2011 Jun 30. Ann Neurol. 2011. PMID: 21721033
-
Therapy of X-linked adrenoleukodystrophy.Expert Rev Neurother. 2008 Sep;8(9):1367-79. doi: 10.1586/14737175.8.9.1367. Expert Rev Neurother. 2008. PMID: 18759549 Review.
-
Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up.Radiographics. 2005 May-Jun;25(3):619-31. doi: 10.1148/rg.253045118. Radiographics. 2005. PMID: 15888613 Review.
Cited by
-
Pathophysiology of X-Linked Adrenoleukodystrophy: Updates on Molecular Mechanisms.J Biotechnol Biomed. 2024;7(2):277-288. doi: 10.26502/jbb.2642-91280151. Epub 2024 Jun 14. J Biotechnol Biomed. 2024. PMID: 39056013 Free PMC article.
References
-
- Moser HW, Moser AB, Smith KD, et al. Adrenoleukodystrophy: phenotypic variability and implications for therapy. J Inherit Metab Dis 1992;15(04):645–664 - PubMed
-
- Raymond GV, Moser AB, Fatemi A X–Linked adrenoleukodystrophy. GeneReviews Available at: https://www.ncbi.nlm.nih.gov/books/NBK1315/. Accessed November 5, 2018
-
- Moser HW, Naidu S, Kumar AJ, Rosenbaum AE. The adrenoleukodystrophies. Crit Rev Neurobiol 1987;3(01):29–88 - PubMed
-
- Korenke GC, Pouwels PJ, Frahm J, et al. Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients. Pediatr Neurol 1996;15(02): 103–107 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources